Drug Type Small molecule drug |
Synonyms S 65487, S 65487/VOB 560, VOB-560 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC41H41ClN6O4 |
InChIKeyVNNWQLOUMFCVJD-XIFFEERXSA-N |
CAS Registry1644600-79-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 2 | FR | 10 Mar 2021 | |
Acute Myeloid Leukemia | Phase 2 | HU | 10 Mar 2021 | |
Acute Myeloid Leukemia | Phase 2 | PL | 10 Mar 2021 | |
Acute Myeloid Leukemia | Phase 2 | KR | 10 Mar 2021 | |
Acute Myeloid Leukemia | Phase 2 | ES | 10 Mar 2021 | |
Acute Myeloid Leukemia | Phase 2 | GB | 10 Mar 2021 | |
Chronic Lymphocytic Leukemia | Phase 1 | AU | 17 Jul 2019 | |
Chronic Lymphocytic Leukemia | Phase 1 | FR | 17 Jul 2019 | |
Chronic Lymphocytic Leukemia | Phase 1 | ES | 17 Jul 2019 | |
Chronic Lymphocytic Leukemia | Phase 1 | GB | 17 Jul 2019 |